{"id":933,"date":"2024-08-30T01:10:36","date_gmt":"2024-08-30T01:10:36","guid":{"rendered":"https:\/\/medicine.nus.edu.sg\/data\/?p=933"},"modified":"2026-01-14T02:19:02","modified_gmt":"2026-01-14T02:19:02","slug":"events-building-a-global-healthtech-leader","status":"publish","type":"post","link":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/","title":{"rendered":"Building a Global Healthtech Leader: Thrixen’s Journey with 22Health Ventures"},"content":{"rendered":"
\n
\n

From Singapore launch to US market penetration\u2014unpacking the strategic decisions behind rapid international expansion in healthcare technology<\/strong><\/p>\n<\/div>\n<\/div>\n

\n
\n

The NUS Medicine Digital Advanced Technology Accelerator (DATA) and Z\u00fchlke presented a case study examining Thrixen’s market expansion journey with 22Health Ventures. The session explored the critical decisions, partnership dynamics, and execution strategies that enabled a Singapore-based healthcare technology venture to successfully penetrate the competitive US healthcare market.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Strategic Insights from Rapid Scale-Up<\/h2>\n<\/div>\n<\/div>\n
\n
\n
    \n
  • Market Expansion Approach<\/strong>
    \nThrixen’s methodology for US market entry following Singapore establishment\u2014including timing decisions, regulatory navigation, and customer acquisition strategies in America’s complex healthcare landscape.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n
    \n
    \n
      \n
    • Investor-Startup Alignment<\/strong>
      \nHow strategic partnerships with specialised healthcare investors like 22Health Ventures provide more than capital\u2014offering market intelligence, regulatory expertise, and critical network introductions that accelerate market penetration.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n
      \n
      \n
        \n
      • Accelerated Growth Execution<\/strong>
        \nThe timeline and operational decisions enabling rapid international expansion whilst maintaining product quality and clinical credibility across different healthcare systems.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n
        \n
        \n
          \n
        • Partnership Frameworks<\/strong>
          \nCollaboration structures between high-growth healthcare startups and strategic investors that balance founder autonomy with investor guidance\u2014particularly crucial when navigating unfamiliar healthcare markets.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n
          \n
          \n

          Learning from Real-World Experience<\/h2>\n<\/div>\n<\/div>\n
          \n
          \n

          Shavit Clein, CEO, Thrixen<\/strong>
          \nShared founder perspectives on strategic decision-making, operational challenges, and lessons learned during international expansion.<\/p>\n<\/div>\n<\/div>\n

          \n
          \n

          Paul Scibetta, Co-Founder, 22Health Ventures<\/strong>
          \nProvided investor insights on evaluating healthcare ventures for international potential and structuring partnerships that accelerate global growth.<\/p>\n<\/div>\n<\/div>\n

          \n
          \n

          The discussion offered actionable frameworks for healthcare founders contemplating international expansion and investors evaluating cross-border healthcare technology opportunities.<\/p>\n<\/div>\n<\/div>\n

          \n
          \n

          Implications for Singapore’s HealthTech Ecosystem<\/h2>\n<\/div>\n<\/div>\n
          \n
          \n

          The session highlighted Singapore’s potential as a launchpad for global healthcare ventures\u2014combining regulatory sophistication, clinical excellence, and strategic geographic positioning. However, sustainable growth often requires strategic partnerships with investors who understand target markets’ unique healthcare landscapes, reimbursement models, and regulatory requirements.<\/p>\n<\/div>\n<\/div>\n

          \n
          <\/div>\n<\/div>\n
          \n
          \n

          Event Details<\/strong>
          \nDate: 30 August 2024
          \nTime: 6:30 PM\u20138:30 PM SGT
          \nVenue: Z\u00fchlke Singapore
          \nAddress: 80 Robinson Road, #22-04, Singapore 068898<\/p>\n<\/div>\n<\/div>\n

          \n
          \n

          Co-organisers:<\/strong> NUS Medicine DATA & Z\u00fchlke<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

          From Singapore launch to US market penetration\u2014unpacking the strategic decisions behind rapid international expansion in healthcare technology The NUS Medicine Digital Advanced Technology Accelerator (DATA) and Z\u00fchlke presented a case study examining Thrixen’s market expansion journey with 22Health Ventures. The session explored the critical decisions, partnership dynamics, and execution strategies that enabled a Singapore-based healthcare […]<\/p>\n","protected":false},"author":1,"featured_media":1492,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"class_list":["post-933","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"acf":[],"yoast_head":"\nBuilding a Global Healthtech Leader: Thrixen's Journey with 22Health Ventures - NUS Medicine Digital Advanced Technology Accelerator<\/title>\n<meta name=\"description\" content=\"Thrixen CEO and 22Health Ventures co-founder discussed strategic healthcare technology market expansion from Singapore to the US at DATA and Z\u00fchlke case study session.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Building a Global Healthtech Leader: Thrixen's Journey with 22Health Ventures - NUS Medicine Digital Advanced Technology Accelerator\" \/>\n<meta property=\"og:description\" content=\"Thrixen CEO and 22Health Ventures co-founder discussed strategic healthcare technology market expansion from Singapore to the US at DATA and Z\u00fchlke case study session.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/\" \/>\n<meta property=\"og:site_name\" content=\"NUS Medicine Digital Advanced Technology Accelerator\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-30T01:10:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-14T02:19:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rupash Pratap\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rupash Pratap\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/\",\"url\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/\",\"name\":\"Building a Global Healthtech Leader: Thrixen's Journey with 22Health Ventures - NUS Medicine Digital Advanced Technology Accelerator\",\"isPartOf\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg\",\"datePublished\":\"2024-08-30T01:10:36+00:00\",\"dateModified\":\"2026-01-14T02:19:02+00:00\",\"author\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#\/schema\/person\/0edf43c101a340f3d4313fa37951e8f6\"},\"description\":\"Thrixen CEO and 22Health Ventures co-founder discussed strategic healthcare technology market expansion from Singapore to the US at DATA and Z\u00fchlke case study session.\",\"breadcrumb\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#primaryimage\",\"url\":\"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg\",\"contentUrl\":\"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Building a Global Healthtech Leader: Thrixen’s Journey with 22Health Ventures\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#website\",\"url\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/\",\"name\":\"NUS Medicine Digital Advanced Technology Accelerator\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#\/schema\/person\/0edf43c101a340f3d4313fa37951e8f6\",\"name\":\"Rupash Pratap\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96ae3f16e84a76378eb288acbcef85d19adf75ecce8cf835f99aa099df84617c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96ae3f16e84a76378eb288acbcef85d19adf75ecce8cf835f99aa099df84617c?s=96&d=mm&r=g\",\"caption\":\"Rupash Pratap\"},\"url\":\"https:\/\/medicine.nus.edu.sg\/data\/author\/medicine\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Building a Global Healthtech Leader: Thrixen's Journey with 22Health Ventures - NUS Medicine Digital Advanced Technology Accelerator","description":"Thrixen CEO and 22Health Ventures co-founder discussed strategic healthcare technology market expansion from Singapore to the US at DATA and Z\u00fchlke case study session.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/","og_locale":"en_US","og_type":"article","og_title":"Building a Global Healthtech Leader: Thrixen's Journey with 22Health Ventures - NUS Medicine Digital Advanced Technology Accelerator","og_description":"Thrixen CEO and 22Health Ventures co-founder discussed strategic healthcare technology market expansion from Singapore to the US at DATA and Z\u00fchlke case study session.","og_url":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/","og_site_name":"NUS Medicine Digital Advanced Technology Accelerator","article_published_time":"2024-08-30T01:10:36+00:00","article_modified_time":"2026-01-14T02:19:02+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg","type":"image\/jpeg"}],"author":"Rupash Pratap","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Rupash Pratap","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/","url":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/","name":"Building a Global Healthtech Leader: Thrixen's Journey with 22Health Ventures - NUS Medicine Digital Advanced Technology Accelerator","isPartOf":{"@id":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#primaryimage"},"image":{"@id":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#primaryimage"},"thumbnailUrl":"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg","datePublished":"2024-08-30T01:10:36+00:00","dateModified":"2026-01-14T02:19:02+00:00","author":{"@id":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#\/schema\/person\/0edf43c101a340f3d4313fa37951e8f6"},"description":"Thrixen CEO and 22Health Ventures co-founder discussed strategic healthcare technology market expansion from Singapore to the US at DATA and Z\u00fchlke case study session.","breadcrumb":{"@id":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#primaryimage","url":"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg","contentUrl":"https:\/\/medicine.nus.edu.sg\/data\/wp-content\/uploads\/sites\/39\/2024\/08\/photo_6244526284382258621_y.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/medicine.nus.edu.sg\/data\/events-building-a-global-healthtech-leader\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/"},{"@type":"ListItem","position":2,"name":"Building a Global Healthtech Leader: Thrixen’s Journey with 22Health Ventures"}]},{"@type":"WebSite","@id":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#website","url":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/","name":"NUS Medicine Digital Advanced Technology Accelerator","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#\/schema\/person\/0edf43c101a340f3d4313fa37951e8f6","name":"Rupash Pratap","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicine.nus.edu.sg\/digital-accelerator\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96ae3f16e84a76378eb288acbcef85d19adf75ecce8cf835f99aa099df84617c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96ae3f16e84a76378eb288acbcef85d19adf75ecce8cf835f99aa099df84617c?s=96&d=mm&r=g","caption":"Rupash Pratap"},"url":"https:\/\/medicine.nus.edu.sg\/data\/author\/medicine\/"}]}},"_links":{"self":[{"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/posts\/933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/comments?post=933"}],"version-history":[{"count":11,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/posts\/933\/revisions"}],"predecessor-version":[{"id":1494,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/posts\/933\/revisions\/1494"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/media\/1492"}],"wp:attachment":[{"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/media?parent=933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/categories?post=933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/data\/wp-json\/wp\/v2\/tags?post=933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}